Article
Genetic variance in ABCB1 and CYP3A5 does not contribute toward the development of chronic kidney disease after liver transplantation.
Pharmacogenetics and genomics - 1 Sept 2014
Tapirdamaz Özlem, Hesselink Dennis A, el Bouazzaoui Samira, Azimpour Mohammad, Hansen Bettina, van der Laan Luc J W, Polak Wojciech G, Kwekkeboom Jaap, van Schaik Ron H N, van Gelder Teun, Metselaar Herold J
Abstract excerpt
INTRODUCTION: Chronic kidney disease (CKD) after liver transplantation (LT) is a major clinical problem that appears to be associated with nongenetic as well as genetic determinants. Calcineurin inhibitor (CNI) use is considered to play a major role in the development of CKD after LT. We studied the influence of single-nucleotide polymorphisms (SNPs) in the genes of the donor and recipient CNI-metabolizing enzyme...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
